78 results
Page 2 of 4
8-K
EX-99.1
k6xycle
26 Apr 23
Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
PRE 14A
ck2atjnj
17 Apr 23
Preliminary proxy
5:04pm
424B5
nfa gwxg1ls3
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
hyz u65guzgjt90ut9s
29 Mar 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
wmx0ekarhz7l8p76uo3
26 Oct 22
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-99.1
vfdnpi0hu
27 Jul 22
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
0doukacp07qox 6w3l
27 Apr 22
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
kfn0a7n90x
9 Feb 22
Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
4:15pm